Protective effect of rhIL-11 in a murine model of acetaminophen-induced hepatotoxicity

Toxicologic Pathology

Volumn 29, Issue 2, 2001, Pages 242-249

  Trepicchio, William L ^a   Bozza, Mary ^a   Bouchard, Page ^a   Dorner, Andrew J ^a  

^a PFIZER INC   (United States)

Author keywords

Acetaminophen; cytokine; inflammation; interleukin 11; liver damage

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; LACTATE DEHYDROGENASE; PARACETAMOL; RECOMBINANT INTERLEUKIN 11; TUMOR NECROSIS FACTOR ALPHA;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CELL ACTIVATION; CELL PROTECTION; DRUG INTOXICATION; FEMALE; GENE EXPRESSION; HISTOPATHOLOGY; KUPFFER CELL; LACTATE DEHYDROGENASE BLOOD LEVEL; LIVER HEMORRHAGE; LIVER NECROSIS; LIVER TOXICITY; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ACETAMINOPHEN; ALANINE TRANSAMINASE; ANIMALS; ASPARTATE AMINOTRANSFERASES; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DOWN-REGULATION; FEMALE; HEMORRHAGE; HEPATITIS, TOXIC; HEPATOCYTES; INJECTIONS, SUBCUTANEOUS; INTERLEUKIN-11; L-LACTATE DEHYDROGENASE; MICE; MICE, INBRED BALB C; NECROSIS; RECOMBINANT PROTEINS; TUMOR NECROSIS FACTOR-ALPHA;

ANIMALIA; MURINAE;

EID: 0035007341     PISSN: 01926233     EISSN: None     Source Type: Journal    
DOI: 10.1080/019262301317052521     Document Type: Article

References (28)

1. Arnaiz SL, Llesuy S., Cutrin JC, Boveris A. (1995). Oxidative stress by acute acetaminophen administration in mouse liver. Free Radical Biol Med 19: 303-310.
2. Arthur MJ, Iredale JP, Mann DA (1999). Tissue inhibitors of metalloproteinases: role in liver fibrosis and alcoholic liver disease. Alcohol Clin Exp Res 23: 940-943.
3. Baumann H., Schendel P. (1991). Interleukin-11 regulates the hepatic expression of the same plasma protein genes as interleukin-6. J Biol Chem 266(30): 20424-20427.
4. Blazka ME, Wilmer JL, Holladay SD, Wilson RE, Luster MI (1995). Role of proinfl ammatory cytokines in acetaminophen hepatotoxicity. Toxicol Appl Pharmacol 133: 43-52.
5. Bozza M., Bliss JL, Maylor R., Erickson J., Donnelly L., Bouchard P., Dorner AJ, Trepicchio WL (1999). Interleukin-11 reduces T cell dependent experimental liver injury in mice. Hepatology 30: 1441-1447.
6. Dorner AJ, Goldman SJ, Keith JC (1997). Interleukin-11: Biological activity and clinical studies. BioDrugs 8: 418-429.
7. Du XX, Doerschuk CM, Orazi A., Williams DA (1994). A bone marrow stromal-derived growth factor, interleukin-11, stimulates recovery of small intestinal mucosal cells after cytoablative therapy. Blood 83(1): 33-37.
8. Felver ME, Mezey E., McGuire M., Mitchell MC, Herlong HF, Veech GA, Veech RL (1990). Plasma tumor necrosis factor alpha predicts decreased long-term survival in severe alcoholic hepatitis. Alcoholism: Clin Exp Res 14: 255-259.
9. Fukuda Y., Sassa S. (1993). Effect of interleukin-11 on the levels of mRNAs encoding heme oxygenase and haptoglobin in human HepG2 hepatoma cells. Biochem Biophys Res Commun 193: 297-302.
10. Kamimura S., Tsukamoto H. (1995). Cytokine gene expression by Kupffer cells in experimental alcoholic liver disease. Hepatology 22: 1304-1309.
11. Laskin DL, Gardner CR, Price VF, Jollow DJ (1995). Modulation of macrophage functioning abrogates the acute hepatotoxicity of acetaminophen. Hepatology 21: 1045-1050.
12. Laskin DL (1990). Parenchymal and nonparenchyma l cell interactions in hepatotoxicity. Adv Exp Med Biol 283: 499-505.
13. Lee SST, Buters JTM, Pineau T., Fernandez-Salguero P., Gonzalez FJ (1996). Role of CYP2E1 in the hepatotoxicity of acetaminophen. J Biol Chem 271: 12063-12067.
14. Lentsch AB, Crouch LD, Jordan JA, Czermak BJ, Yun EC, Guo R., Sarma V., Diehl KM, Ward PA (1999). Regulatory effects of Interleukin-11 during acute lung infl ammatory injury. J Leuk Biol 66: 151-157.
15. Mitchell JR, Jollow DJ, Potter WZ, Davis DC, Gollette JR, Brodie BB (1973). Acetaminophen-induce d hepatic necrosis. IV. Role of glutathione. J Pharmacol Exp Ther 187: 211-217.
16. Morris JC, Neben S., Bennett F., Finnerty H., Long A., Beier DR, Kovacic S., McCoy JM, DiBlasio-Smith E., LaVallie ER, Caruso A., Calvetti J., Morris G., Weich N., Paul SR, Crosier PS, Turner KJ, Wood CR (1996). Molecular cloning and characterization of murine interleukin-11. Ex Hematol 24: 1369-1376.
17. Parks WC, Mecham RP (1998). Matrix Metalloproteinases. Academic Press, San Diego.
18. Paul SR, Schendel P. (1992). The cloning and biological characterization of recombinant human interleukin 11. Int J Cell Cloning 10: 135-143.
19. Pfeiffer CJ, Sato S., Qui BS, Keith JC, Evangelista S. (1997). Cellular pathology of experimental colitis induced by trinitrobenzenesulphoni c acid (TNBS): Protective effects of recombinant human Interleukin-11. Inflammopharm 5: 383-381.
20. Peterson RL, Wang L., Albert L., Keith JC, Dorner AJ (1998). Molecular effects of recombinant human Interleukin-11 in the HLA-B27 rat model of infl ammatory bowel disease. Lab Invest 78: 1503-1512.
21. Redlich CA, Gao X., Rockwell S., Kelley M., Elias JA (1996). IL-11 enhances survival and decreases TNF production after radiation-induced thoracic injury. J Immunol 157(4): 1705-10.
22. Roeb E., Graeve L., Hoffmann R., Decker K., Edwards DR, Heinrich PC (1993). Regulation of tissue inhibitor of metalloproteinases-1 gene expression by cytokines and dexamethasone in rat hepatocyte primary cultures. Hepatology 18(6): 1437-1442.
23. Schendel PF, Turner KJ (1998). Interleukin-11. In: Cytokines, Mire-Sluis A, Thorpe R (eds). Academic Press, London, pp 169-182.
24. Sonis ST, Van Vugt AG, McDonald J., Dotoli E., Schwertshlag U., Szklut P., Keith JC (1997). Mitigating effects of interleukin 11 on consecutive courses of 5-flurouracil-induced ulcerative mucositis in hamsters. Cytokine 9: 605-612.
25. Tilg H., Dinarello CA, Mier JW (1997). IL-6 and APPs: Anti-infl ammatory and immunosuppressive mediators. Immunol Today 18: 428-432.
26. Trepicchio WL, Bozza M., Pedneault G., Dorner A. (1996). Recombinant human IL-11 attenuates the infl ammatory response through down-regulation of proinfl ammatory cytokine release and nitric oxide production. J Immunol 157(8): 3627-3634.
27. Trepicchio WL, Wang L., Bozza M., Dorner AJ (1997). IL-11 regulates macrophage effector function through inhibition of Nuclear Factor-k B. J Immunol 159: 5661-5670.
28. Willis D., Moore AR, Frederick R., Willoughby DA (1996). Heme oxygenase: A novel target for modulation of the infl ammatory response. Nature Med 2: 87-90.